Paper9517872
Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.
Napoli PA and 6 others. Eur J Epidemiol, 1998. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy. Papers, record 9517872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9517872
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| Pneumocystis | Major topic |
| Pneumonia, Pneumocystis | Major topic |
| Practice Patterns, Physicians' | Major topic |
| Adolescent | |
| Adult | |
| CD4 Lymphocyte Count | |
| Child | |
| Female | |
| Humans | |
| Italy | |
| Male |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8709686 | Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee. | Lancet | 1996 | https://conductscience.org/library/papers/8709686 | PubMed |
| 2 | 2203263 | State-of-the-art conference on azidothymidine therapy for early HIV infection. | Am J Med | 1990 | https://conductscience.org/library/papers/2203263 | PubMed |
| 3 | 7985892 | Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group. | Ann Intern Med | 1995 | https://conductscience.org/library/papers/7985892 | PubMed |
| 4 | 1970466 | The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. | Ann Intern Med | 1990 | https://conductscience.org/library/papers/1970466 | PubMed |
| 5 | 8094208 | Expanded European AIDS case definition. | Lancet | 1993 | https://conductscience.org/library/papers/8094208 | PubMed |
| 6 | 8813038 | A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8813038 | PubMed |
| 7 | 8656507 | Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. | JAMA | 1996 | https://conductscience.org/library/papers/8656507 | PubMed |
| 8 | 3299089 | The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3299089 | PubMed |
| 9 | 7491007 | Impact of treatment and prophylaxis on presentation and survival of patients with AIDS in Milan. | Lancet | 1995 | https://conductscience.org/library/papers/7491007 | PubMed |
| 10 | 8151850 | Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. | JAMA | 1994 | https://conductscience.org/library/papers/8151850 | PubMed |
| 11 | 7901434 | Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. | JAMA | 1993 | https://conductscience.org/library/papers/7901434 | PubMed |
| 12 | 8097082 | Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8097082 | PubMed |
| 13 | 8806255 | Will we ever know when to treat HIV infection? | BMJ | 1996 | https://conductscience.org/library/papers/8806255 | PubMed |
| 14 | 8581117 | The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994. | Commun Dis Rep CDR Rev | 1996 | https://conductscience.org/library/papers/8581117 | PubMed |
| 15 | 8096582 | Preliminary analysis of the Concorde trial. Concorde Coordinating Committee. | Lancet | 1993 | https://conductscience.org/library/papers/8096582 | PubMed |
| 16 | 8658159 | HIV therapeutics. | Science | 1996 | https://conductscience.org/library/papers/8658159 | PubMed |
| 17 | 8633824 | Protease inhibitors for HIV infection. | Ann Intern Med | 1996 | https://conductscience.org/library/papers/8633824 | PubMed |
| 18 | 8813990 | Antiretroviral drugs for AIDS. | Lancet | 1996 | https://conductscience.org/library/papers/8813990 | PubMed |
| 19 | 8172439 | Prophylaxis for opportunistic infections in patients with HIV infection. | Ann Intern Med | 1994 | https://conductscience.org/library/papers/8172439 | PubMed |
| 20 | 1969115 | Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. | N Engl J Med | 1990 | https://conductscience.org/library/papers/1969115 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31999715 | Impact of chemorophylaxis policy for AIDS-immunocompromised patients on emergence of bacterial resistance. | PLoS One | 2020 | https://conductscience.org/library/papers/31999715 | PubMed |
| 11287693 | Sexual behaviour of heterosexual individuals with HIV infection naive for antiretroviral therapy in Italy. | Sex Transm Infect | 2001 | https://conductscience.org/library/papers/11287693 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9517872
GET https://conductscience.org/api/papers/v1/9517872/references?page=2